Financials Geratherm Medical AG
Equities
GME
DE0005495626
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.6 EUR | 0.00% | +13.30% | -14.81% |
2023 | Geratherm Medical AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
2023 | Geratherm Medical AG Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Valuation
Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 43.81 | 41.48 | 27.17 | 24.97 | 24.97 | - |
Enterprise Value (EV) 1 | 43.81 | 41.48 | 27.17 | 21.57 | 22.67 | 20.07 |
P/E ratio | 38.5 x | 419 x | 25 x | 17.7 x | -92 x | 21.9 x |
Yield | 4.52% | - | - | 4.57% | - | 3.7% |
Capitalization / Revenue | 2.04 x | - | - | 0.99 x | 1.26 x | 1.07 x |
EV / Revenue | 2.04 x | - | - | 0.85 x | 1.14 x | 0.86 x |
EV / EBITDA | 15.6 x | - | - | 4.69 x | 15.1 x | 4.46 x |
EV / FCF | - | - | - | 8.29 x | 227 x | 7.72 x |
FCF Yield | - | - | - | 12.1% | 0.44% | 13% |
Price to Book | 2.16 x | - | - | 1.06 x | 1.13 x | 1.06 x |
Nbr of stocks (in thousands) | 4,950 | 4,950 | 5,445 | 5,427 | 5,427 | - |
Reference price 2 | 8.850 | 8.380 | 4.990 | 4.600 | 4.600 | 4.600 |
Announcement Date | 25/04/19 | 26/04/22 | 29/06/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 21.52 | - | - | 25.3 | 19.8 | 23.3 |
EBITDA 1 | 2.801 | - | - | 4.6 | 1.5 | 4.5 |
EBIT 1 | 1.987 | - | - | 3.2 | -0.3 | 2.4 |
Operating Margin | 9.23% | - | - | 12.65% | -1.52% | 10.3% |
Earnings before Tax (EBT) 1 | - | - | - | 3 | -0.5 | 2.1 |
Net income 1 | 1.154 | 0.1222 | 1.023 | 1.4 | -0.3 | 1.2 |
Net margin | 5.36% | - | - | 5.53% | -1.52% | 5.15% |
EPS 2 | 0.2300 | 0.0200 | 0.2000 | 0.2600 | -0.0500 | 0.2100 |
Free Cash Flow 1 | - | - | - | 2.6 | 0.1 | 2.6 |
FCF margin | - | - | - | 10.28% | 0.51% | 11.16% |
FCF Conversion (EBITDA) | - | - | - | 56.52% | 6.67% | 57.78% |
FCF Conversion (Net income) | - | - | - | 185.71% | - | 216.67% |
Dividend per Share 2 | 0.4000 | - | - | 0.2100 | - | 0.1700 |
Announcement Date | 25/04/19 | 26/04/22 | 29/06/23 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | - | - | - | 3.4 | 2.3 | 4.9 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | - | 2.6 | 0.1 | 2.6 |
ROE (net income / shareholders' equity) | - | - | - | 8.5% | -1.7% | 6.1% |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share 2 | 4.110 | - | - | 4.330 | 4.060 | 4.320 |
Cash Flow per Share 2 | - | - | - | 0.7200 | 0.1400 | 0.6100 |
Capex 1 | - | - | - | 2 | 1.6 | 1.6 |
Capex / Sales | - | - | - | 7.91% | 8.08% | 6.87% |
Announcement Date | 25/04/19 | 26/04/22 | 29/06/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.81% | 26.91M | |
-3.54% | 185B | |
-0.58% | 109B | |
-2.74% | 68.54B | |
+4.84% | 51.74B | |
+10.40% | 45.22B | |
+3.12% | 41.74B | |
+2.87% | 26.69B | |
+4.61% | 26.83B | |
+11.62% | 25.63B |
- Stock Market
- Equities
- GME Stock
- Financials Geratherm Medical AG